Cargando…

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy

Recent type 2 diabetes guidance from the UK’s National Institute for Health and Care Excellence (NICE) proposes offering SGLT2-inhibitor therapy to people with established atherosclerotic cardiovascular disease (ASCVD) or heart failure, and considering SGLT2-inhibitor therapy for those at high-risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Katherine G., Hopkins, Rhian, Shields, Beverley M., Thomas, Nicholas J., McGovern, Andrew P., Dennis, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623735/ https://www.ncbi.nlm.nih.gov/pubmed/37919773 http://dx.doi.org/10.1186/s12933-023-02032-x

Ejemplares similares

Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation
por: McGovern, Andrew P, et al.
Publicado: (2020)

SGLT2 inhibitors and renal complications in type 1 diabetes
por: Petrie, John R
Publicado: (2020)

The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?
por: Murray, Scott W., et al.
Publicado: (2021)

Lack of durable natriuresis and objective decongestion following SGLT2 inhibition in randomized controlled trials of patients with heart failure
por: Packer, Milton
Publicado: (2023)

EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors
por: Fernández-Fernandez, Beatriz, et al.
Publicado: (2023)

Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
por: Verma, Subodh
Publicado: (2020)

Empagliflozin and Protecting Microvascular Support of Heart Mechanics: SGLT2 Inhibition or More?
por: Mantsounga, Chris Sorel, et al.
Publicado: (2019)

Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use
por: McGovern, Andrew, et al.
Publicado: (2017)

Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol)
por: McGovern, Andrew, et al.
Publicado: (2017)

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

Journal Production Guidance for Software and Data Citations
por: Stall, Shelley, et al.
Publicado: (2023)

New international guidance on quality, safety and efficacy of DNA vaccines
por: Beasley, David W. C.
Publicado: (2020)

Human milk banks: a need for further evidence and guidance
por: Fang, Mirriam Tyebally, et al.
Publicado: (2021)

Research in forced displacement: guidance for a feminist and decolonial approach
por: Singh, Neha S, et al.
Publicado: (2021)

Thrombosis and Hemophilia: Little More Evidence, Much More Guidance
por: Hermans, Cedric
Publicado: (2023)

The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model
por: Ha, Chae-Myeong, et al.
Publicado: (2019)

The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
por: Young, Katherine G., et al.
Publicado: (2022)

Centring sexual and reproductive health and justice in the global COVID-19 response
por: Hall, Kelli Stidham, et al.
Publicado: (2020)

Defining a Role and Mechanism for Igcam Function in Vertebrate Axon Guidance
por: Rutishauser, Urs
Publicado: (2000)

EU guidance impedes humanitarian action to prevent COVID-19 in Syria
por: Hussain, Hamid Yahiya, et al.
Publicado: (2020)

A promising inactivated whole-virion SARS-CoV-2 vaccine
por: Isakova-Sivak, Irina, et al.
Publicado: (2021)

Correction to: The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
por: Young, Katherine G., et al.
Publicado: (2023)

Offline: What is the UK for?
por: Horton, Richard
Publicado: (2021)

Comment on Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures. Toxins 2017, 10, 18—Quintessential Use of Ultrasound Guidance for Botulinum Toxin Injections—Muscle Innervation Zone Targeting Revisited
por: Kaymak, Bayram, et al.
Publicado: (2018)

Guidance on guideline adherence
por: Peters, R.J.G.
Publicado: (2015)

Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems
por: Moore, Luke S P
Publicado: (2020)

Pre-assessment and management of long COVID patients requiring elective surgery: challenges and guidance
por: Boles, Sophie, et al.
Publicado: (2023)

Towards better contact-tracing in the UK
por: Cook, Alex R, et al.
Publicado: (2020)

FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine
por: Luh, Frank, et al.
Publicado: (2018)

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020)

COVID-19 will continue but the end of the pandemic is near
por: Murray, Christopher J L
Publicado: (2022)

Seeding the idea of encapsulating a representative synthetic metagenome in a single yeast cell
por: Belda, Ignacio, et al.
Publicado: (2021)

UK Biobank: a model for public engagement?
por: Levitt, Mairi
Publicado: (2005)

Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK
por: Nadesalingam, Angalee, et al.
Publicado: (2021)

The future of near-field communication-based wireless sensing
por: Olenik, Selin, et al.
Publicado: (2021)

Recent advances in uncovering the mechanisms contributing to BIRD-2-induced cell death in B-cell cancer cells
por: Kerkhofs, Martijn, et al.
Publicado: (2019)

The political theatre of the UK's travel ban on South Africa
por: Mendelson, Marc, et al.
Publicado: (2021)

Personalised medicine in the UK: challenges of implementation and impact on healthcare system
por: Pokorska-Bocci, Anna, et al.
Publicado: (2014)

Observational study of UK mobile health apps for COVID-19
por: Chidambaram, Swathikan, et al.
Publicado: (2020)

Impacts of COVID-19 on vulnerable children in temporary accommodation in the UK
por: Rosenthal, Diana Margot, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lc3n58l6urecfkj7oh5ddiftl6